Respond to prefers-color-scheme dark in app web views

Follow section front redirects in Spectrum

Enable NLP source in PCS for load testing

Switch off the News Alerts Survey Widget when we have enough responses

Poll to determine if new LUF updates are available

Allows the winning A/B test variant to be turned on without Spectrum deployment

Show infinite scrolling sections in Assembler MultiView

Show option for NLP article summaries in Action Bar

Show NLP summaries collection recirc on article pages

A general feature flag for Recipe Features that aren't yet released

Feature flag for media team features that aren't yet released

Use new Orca video player for preroll plugin in Spectrum

Show the snow tracker (instead of the heat tracker) on Spectrum

Tens of thousands in Georgia protest Russian-style ‘foreign agents’ law

Israel says 300,000 fled Gaza fighting; military expands operation in Rafah

Israel orders more Rafah evacuations, expanding military operation

Claire Messud turns her family’s history into a masterpiece

Kristi Noem’s dog killing is pure Southern gothic

Joseph Epstein, conservative provocateur, tells his life story in full

The urgent air defense lessons of April 16 

Are smartphones destroying childhood? It’s complicated.

In the campaign against Donald Trump, do the ends justify the means?

Cruise ship drags dead whale into New York, prompting investigation

5 big travel lessons from an accomplished conservationist

The case for eating at Italian gas stations

I used to dismiss my mom’s advice. Then I found a note she wrote before she died.  

Photos of his mom at lunch are a balm people didn’t know they needed

Dog hit by car loses leg, is adopted by firefighter who helped her

Eighth-inning decision burns the Nats in a 4-2 loss to the Red Sox

Commanders rookie DT Johnny Newton needs a second foot surgery

Nats win opener at Fenway behind Patrick Corbin and a lockdown bullpen

An unexpected sight to behold: Ted Cruz working bipartisan deals

Narrative of Trump snoozing in court takes hold — much to his annoyance

Manafort will no longer take on Republican convention role

Courtroom photo ban adds to hurdles for Trump trial journalists

Israel’s shameful ban on Al Jazeera

Checks, not sex, and other takeaways from Trump’s New York hush money trial

Fooled by AI? These firms sell deepfake detection that’s ‘REAL 100%.’ 

Apple apologizes for iPad ad after blowback 

Google’s new ‘Find My’ device network is useful but a stalking risk

In photos: Scenes from the grand final of the 2024 Eurovision competition

Bishop vanished. His species can still be saved.

Northern lights glow worldwide

‘Bunker mentality’ at Columbia lit protest spark that spread nationwide

A mystery illness stole their kids’ personalities. These moms fought for answers.

The greatness — yes, greatness — of the Planet of the Apes

Ask Amy: Mother isn’t accepting of her gay son

Carolyn Hax: Keep scrolling seven hours per day, or give therapy a try?

Miss Manners: Journalist posts on social media about a typo at another outlet

US-POLITICS-BIDEN

Health

Well+Being

Opinions

Higher Education

Education

https://www.washingtonpost.com/coronavirus/

Coronavirus pandemic

Tazeen Qureshy

NEW DELHI — Early on Saturday, Kartik Naik waited in line with doctors, nurses and medical students in a small city on India's eastern coast, unaware that he was making history.

The 44-year-old works as a hospital janitor. When the pandemic swept through the region, he witnessed some of the worst: His job was to shift the dead to the morgue.

Now Naik is part of a leap forward in the country’s long battle against the <a href="https://www.washingtonpost.com/coronavirus/" target="_blank" class="contextual_link">coronavirus</a>, becoming one of the first Indians to receive a vaccine dose in what is likely to be the world’s largest vaccination campaign.

“I am told this vaccine will drive covid away,” Naik said. The “rest is up to God.”

India on Saturday kicked off its nationwide vaccination drive at thousands of centers across the country, part of a bold bid to immunize 300 million people by this summer.

It’s a vital undertaking in a nation that has recorded more coronavirus cases than any other place on Earth except the United States.

The effort is being buoyed by two locally made vaccines and India’s prior experience with large-scale immunization campaigns. But what might have been a triumph for the country’s vaccine industry has been dogged by controversy.

T. Narayan

The Indian government granted emergency approval to two vaccines — a locally manufactured version of the Oxford-AstraZeneca vaccine and a vaccine called Covaxin developed by Bharat Biotech, an Indian pharmaceutical company.

Only the Oxford-AstraZeneca vaccine has completed a Phase 3 clinical trial for safety and efficacy. Bharat Biotech has finished earlier-stage trials on its vaccine but has provided no data on whether it works. Yet both vaccines are being administered, and people cannot choose which vaccine they receive.

Complicating matters further, Indian regulators said the Bharat Biotech vaccine will be used in “clinical trial mode,” a phrase that left experts baffled. One of India’s foremost vaccine experts, Gagandeep Kang, <a href="https://timesofindia.indiatimes.com/india/i-have-no-clue-i-have-never-seen-anything-like-it/articleshow/80087336.cms">told an interviewer that she had “no clue”</a> what it meant.

Dhiraj Singh

India is starting its vaccination campaign at a moment when the virus is in retreat — unlike in the United States and Britain. New cases have dropped drastically since peaking in September: India is recording about <a href="https://ourworldindata.org/coronavirus/country/india?country=~IND" title="ourworldindata.org">18,000 cases</a> and 200 deaths a day.

Indian Prime Minister Narendra Modi urged Indians to remain vigilant in a televised address on Saturday, adding that the vaccine drive was “living proof of India’s talent.” Vaccinations began at 3,000 sites across the country, and authorities say the number will grow in the coming weeks. More than <a href="https://twitter.com/mohfw_india/status/1350446928169820170?s=21" title="twitter.com">191,000 people </a>were vaccinated on the first day, falling short of the initial target.

The Indian government began by purchasing 16 million doses of the two vaccines, both <a href="https://www.livemint.com/news/india/at-what-cost-is-govt-sourcing-serum-s-covishield-bharat-biotech-s-covaxin-explained-11610450615485.html">sold at $2.75 a dose</a> (the Pfizer vaccine, by comparison, <a href="https://www.washingtonpost.com/health/2020/12/23/coronavirus-vaccine-pfizer/">costs $19.50</a>). The AstraZeneca vaccine is being manufactured by Serum Institute of India, the world’s largest vaccine maker by volume. Neither the AstraZeneca vaccine nor the Bharat Biotech vaccine requires ultracold storage, a crucial plus in a country where such refrigeration is scarce.

The <a href="https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf">first in line</a> for vaccinations are 30 million health-care workers, soldiers and municipal employees. They’ll receive vaccinations free of cost. The next stage is more ambitious: It will target 270 million people over the age of 50 as well as those below 50 who have co-morbidities.

The rollout of the vaccine program matters not just for India, but <a href="https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-india-serum-institute/2020/11/10/bbd7509c-0fb0-11eb-bfcf-b1893e2c51b4_story.html">for the entire developing world</a>. India has a long track record of mass-producing vaccines at affordable prices.

Serum Institute will be a major supplier to the Covax project, a global initiative backed by the World Health Organization to distribute vaccines equitably to poorer countries. Adar Poonawalla, the chief executive of Serum Institute, said the company would start delivering doses to Covax by the end of this month.

The success of India’s vaccination campaign effort will become clear only in the coming months. There were no reports of ­large-scale problems on Day 1, although the state of Maharashtra will suspend further immunizations for two days due to a ­software issue.

In many vaccination centers, there was joy and relief. At Delhi’s Lok Nayak hospital, a sprawling facility that has treated more than 10,000 covid-19 patients, chains of marigolds garlanded the pathway leading to the vaccination center. Suresh Kumar, the hospital’s medical director, was beaming. “This menace, this crisis, is over,” he said.

Along with celebration, however, there were signs of unease, particularly at hospitals administering Covaxin. At JJ Hospital in Mumbai, a government-run facility, 100 people were called to receive the Bharat Biotech vaccine, but only 39 arrived. Ranjit Mankeshwar, the hospital’s dean, said it was too soon to gauge whether health workers were reluctant to get Covaxin. Mankeshwar said he received Covaxin without hesitation on Saturday.

Unlike the AstraZeneca vaccine, people receiving Covaxin were asked to sign a consent form that noted its “clinical efficacy has yet to be established.” Nupur Abrol, a 35-year old anesthesiologist at Ram Manohar Lohia hospital in Delhi, said she came to the hospital thinking she would refuse to get the shot. She changed her mind after seeing one of the country’s top doctors get Covaxin on television.

“We don’t know the efficacy of the vaccine, but we won’t be eligible for the other vaccine,” Abrol said, adding that she is praying it works. Abrol said the past year had been “horrid.” Her regular stints in the covid-19 intensive care unit meant frequent separations from her 3-year-old son.

India managed the towering logistical feat of distributing vaccine doses across the country with a synchronized national launch. Still, overcoming apprehensions about new vaccines remains a challenge. Lahu Kumethe, the medical superintendent of a rural hospital in Rajora in central India, said 100 recipients were invited to get the AstraZeneca vaccine on Saturday but only half showed up. “People were nervous,” he said, although the mood at the center shifted after the first vaccinations unfolded with no ill effects.

The AstraZeneca vaccine represented the large majority of vaccinations administered on Saturday, but Covaxin was also a key part of the launch. Anant Bhan, a public health and bioethics expert, said that the government’s approval of the Bharat Biotech vaccine raised many <a href="https://twitter.com/AnantBhan/status/1349757508525559811?s=20">unanswered questions</a>. Critics of the government went further. “Indians are not guinea pigs,” Manish Tewari, a spokesman for the opposition party<a href="https://www.aninews.in/news/national/general-news/indians-are-not-guinea-pigs-you-cant-use-covaxin-rollout-as-phase-3-trial-manish-tewari20210114003038/">, told Asian News International</a>.

Some experts worry that the lack of transparency in the process of approving vaccines for emergency use could undermine confidence in them more broadly. That would represent a break from the past in India, a place where vaccine skepticism has been low and immunization is seen as an essential tool in reducing mortality.

Such concerns aside, ­health-care workers welcomed the advent of vaccines. Pragati Raut, a 44-year-old nurse in Mumbai, has been on covid-19 duty throughout the pandemic. She has seen patients succumb to the disease. In August, she was infected and hospitalized for 10 days. On Saturday, she helped administer the first round of shots at BYL Nair Charitable Hospital. “It feels like a full circle,” Raut said.

On the other side of the country in the eastern state of Odisha, a doctor supervising a vaccination drive expressed a similar sentiment. “It is difficult to describe what this day means to doctors like us,” said Amulya Kumar, 53. “For months, we have been on our toes, working day and night to cure covid patients.” Now, he said, this “could be the beginning of the end.”


<attribution>
<email>niha.masih@washpost.com</email>
</attribution>


Tazeen Qureshy in Berhampur, Jyoti Shelar in Mumbai and Taniya Dutta in New Delhi contributed to this report.


India approves two vaccines as it prepares for massive immunization push



Who will make coronavirus vaccines for the developing world? India holds the key



The virus is on the march in much of the world. In India, it’s in retreat.


Daniel Pearl Award for Outstanding Coverage of South Asia, South Asian Journalists Association Awards, 2022

Member of "The Pegasus Project" team, George Polk Awards, 2021

Winner, South Asian Journalists Association Awards, 2021

Ramnath Goenka Award for Foreign Correspondent Covering India, 2021 and 2020

Journalist of the Year, Canadian National Newspaper Awards, 2015

Winner, International coverage, Canadian National Newspaper Awards, 2015

Young Journalist Award, Society of Publishers in Asia, 1998

Smith College, BA 

Columbia University, MA in International Affairs and MS in Journalism

Joanna Slater is a national correspondent for The Washington Post focusing on the Northeast. Previously she served as the India bureau chief based in New Delhi. Prior to joining The Post, she was a foreign correspondent for the Globe & Mail and a reporter at the Wall Street Journal. Her postings include assignments in Mumbai, Hong Kong and Berlin. 

Joanna Slater

SAJA Daniel Pearl Award 2022 (India under Surveillance)

SAJA Award for Business Reporting 2022 (Facebook under Fire)

Member of the team to win the George Polk Award for Technology Reporting 2021 (The Pegasus Project)

Honorable mention, SABEW Award 2021 (Facebook Papers)

New York Society for Professional Journalists Award, 2016

Radio Digital Television Network Foundation Fellow, 2016

Inlaks Shivdasani Foundation Scholar, 2015

Honorable mention, World Media Summit Global Awards, 2014

Toto Funds the Arts Award, 2013

Delhi University, BA in English

Columbia Graduate School of Journalism, MA in Journalism

Niha Masih is a reporter at The Washington Post's Seoul hub, where she covers breaking news in the United States and across the world. Previously, she was The Post's correspondent in India, where she covered the rise of majoritarian nationalism, conflict in Kashmir, the covid crisis and digital surveillance of citizens.

Niha Masih

The Washington Post

India launches vaccination campaign, one of the world's largest

Bloomberg

One of the World?s Biggest Vaccine Campaigns Starts in India

U.S. cases and deaths by state

World map

New CDC guidance

When am I still contagious?

The people who never get covid

Coronavirus

iptc-media/health

iptc-media/health/health_treatment/preventative_medicine

iptc-media/health/diseases_and_conditions

iptc-media/health/health_treatment

iptc-media/health/diseases_and_conditions/communicable_disease/virus_disease/retrovirus

iptc-media/health/diseases_and_conditions/illness

iptc-media/economy_business_and_finance

iptc-media/health/health_treatment/medicine

iptc-media/health/diseases_and_conditions/communicable_disease/virus_disease

iptc-media/health/diseases_and_conditions/communicable_disease

iptc-media/health/health_treatment/preventative_medicine/vaccines

iptc-media/economy_business_and_finance/economic_sector/chemicals

client-blocklists/Client List: Morgan Stanley KWs - INCLUDES ANY

client-blocklists/Amazon KWs - EXCLUDE ALL 

client-blocklists/Client List: Becton Dickinson KWs - EXCLUDES ALL

client-blocklists/CLIENT LIST: Nomura KWs 2021 - EXCLUDES ALL

client-blocklists/Boeing KWs 2021- INCLUDE ANY

client-blocklists/Bed Bath & Beyond KWs - INCLUDE ANY

client-blocklists/Client List: Exxon Mobil  - INCLUDES ANY

client-blocklists/Client List: T. Rowe Price KWs - EXCLUDES ALL

client-blocklists/T. Rowe Price KWs - EXCLUDES ALL

client-blocklists/Client List: Microsoft KWs 2 - INCLUDES ANY

advertising/B2_Automotive Interest 2.5.15_legacyaux_jqs

advertising/B2_BioPharmaceuticals_legacyaux_p81

client-blocklists/HBO KWs - INCLUDES ANY

client-blocklists/Ford/Lincoln KWs - INCLUDES ANY

client-blocklists/Bank of America KWs - EXCLUDES ALL

client-blocklists/Client List: Diageo - Johnnie Walker KWs - INCLUDES ANY

advertising/Flu, Sickness & Virus Content

client-blocklists/WaPo: Combined Disaster Keyword List - INCLUDES ANY

client-blocklists/ExxonMobil 03312021 KWs - INCLUDES ALL

advertising/Coronavirus Content

client-blocklists/GEICO KWs - INCLUDES ANY_4.26.21

client-blocklists/Client List: Optum KWs - EXCLUDES ALL

client-blocklists/Client List: Navy Federal Credit Union NFCU KWs 2 - EXCLUDES ALL - 12.23.20

client-blocklists/Client List: Eli Lily KWs - INCLUDES ANY

advertising/B2_Data Center Buyer_legacyaux_80A

advertising/B2_Digital Authentication_legacyaux_c2u

client-blocklists/Client List: Purina KWs - INCLUDES ANY

advertising/B2_Health Care Policy Enthusiast_legacyaux_7ny

advertising/B2_Health_legacyaux_q5h

advertising/Client Keywords: On Running

client-blocklists/BP KWs - INCLUDES ANY

advertising/B2_Pharmaceuticals_legacyaux_ar0

advertising/B2_Positive News_legacyaux_hlt

advertising/B2_Retirement Planners 2.12.15_legacyaux_k9i

advertising/B2_Science, Health & Technology_legacyaux_wkq

client-blocklists/Client List: KPMG KWs - EXCLUDES ALL

client-blocklists/Client List: Navy Federal Credit Union NFCU KWs - EXCLUDES ALL

client-blocklists/Client List: Novo Nordisk KWs - EXCLUDES ALL

client-blocklists/Client List: Siemens KWs - EXCLUDES ALL

client-blocklists/Client List: Cisco KWs - INCLUDES ANY

client-blocklists/Client List: AT&T ALT KWs - INCLUDES ANY

client-blocklists/Mercedes KWs - INCLUDES ANY

client-blocklists/FX Excludes All Disney

client-blocklists/Client List: Inpixon KWs - INCLUDES ANY

client-blocklists/Client List: Boeing KWs - INCLUDES ANY

client-blocklists/Client List: Google KWs - INCLUDES ALL

client-blocklists/Client List: AT&T KWs 2021 - INCLUDES ANY

client-blocklists/Philip Morris KWs - INCLUDES ANY 

client-blocklists/Dupixent neg kws - EXCLUDES ALL

client-blocklists/Capital One KWs 2 - INCLUDES ANY - 1.4.21

client-blocklists/Bank of America Merrill Lynch KWs - INCLUDES ANY

client-blocklists/CME KWs - EXCLUDES ALL

client-blocklists/Google PG KWs - INCLUDES ANY

client-blocklists/Client List: Office Depot KWs - EXCLUDES ALL

client-blocklists/Chase KWs - EXCLUDES ALL

client-blocklists/Client List: ETrade KWs - EXCLUDES ALL

prism://prism.query/site,/world/asia-pacific&limit=20

Asia

The Washington Post provides the latest information and analysis of breaking Asia news stories. Includes news coverage on China, Japan, North Korea, South Korea, Vietnam, Indonesia, Malaysia, Taiwan and Cambodia.

prism://prism.query/site-articles-only,/world/&limit=20

Are you on Telegram? Subscribe to our channel for the latest updates on Russia’s war in Ukraine.

World

The Washington Post World section provides information and analysis of breaking world news stories. In addition to our world news and video, Post World News offers discussions and blogs on major international news and economic issues.

prism://prism.query/ap-articles-by-site-id,/world